Loading...
Richterthemis Medicare India Private Limited — Lisinopril Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #12 for Lisinopril · $150.0K export value · DGFT Verified
Richterthemis Medicare India Private Limited is the #12 Indian exporter of Lisinopril with $150.0K in export value and 3 verified shipments. Richterthemis Medicare India Private Limited holds a 0.2% market share in Lisinopril exports across 1 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $3.9M | 78 | 19.6% |
| NIGERIA | $3.7M | 99 | 18.6% |
| UNITED KINGDOM | $2.3M | 95 | 11.5% |
| NETHERLANDS | $1.7M | 34 | 8.5% |
| SOUTH AFRICA | $1.4M | 110 | 6.9% |
| MALTA | $1.0M | 131 | 5.3% |
| NEW ZEALAND | $948.1K | 45 | 4.8% |
| TURKMENISTAN | $913.8K | 57 | 4.6% |
| TURKEY | $849.2K | 18 | 4.3% |
| YEMEN | $740.9K | 146 | 3.7% |
India exports Lisinopril to 94 countries. The top destination is UNITED STATES (19.6%), followed by NIGERIA and UNITED KINGDOM.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LUPIN PHARMACEUTICAL INC | UNITED STATES | $1.4M | 28 |
| BROWN AND BURK UK LIMITED | UNITED KINGDOM | $852.4K | 19 |
| XXPINXXHARXXCEUXXCALXXINC | UNITED STATES | $850.0K | 17 |
| HAWKARY PHARMACEUTICAL COMPANY# | TURKEY | $619.4K | 13 |
| APL SWIFT SERVICES (MALTA) LTD., |
India exported $15.9M worth of Lisinopril through 3,514 shipments from 221 suppliers to 94 countries, serving 450 buyers globally. Richterthemis Medicare India Private Limited contributes $150.0K to this total, accounting for 0.2% of India's Lisinopril exports.
Richterthemis Medicare India Private Limited's average Lisinopril shipment value is $50.0K per consignment, based on 3 shipments totaling $150.0K.
Richterthemis Medicare India Private Limited ranks #12 among 221 Indian Lisinopril exporters with a 0.2% market share. The top 3 exporters are LUPIN LIMITED ($4.3M), IPCA LABORATORIES LIMITED ($2.7M), MICRO LABS LIMITED ($1.9M). Richterthemis Medicare India Private Limited processed 3 shipments to 1 destination countries.
What Richterthemis Medicare India Private Limited must comply with to export Lisinopril to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | STALLION LABORATORIES PRIVATE LIMITED | $300.0K | 6 | 1 | $50.0K |
| 5 | MACLEODS PHARMACEUTICALS LTD | $150.0K | 3 | 3 | $50.0K |
| 12 | RICHTERTHEMIS MEDICARE INDIA PRIVATE LIMITED ★ | $150.0K | 3 | 1 | $50.0K |
Richterthemis Medicare India Private Limited ranks #12 among 221 Indian Lisinopril exporters. Average shipment value of $50.0K compared to the market average of $72.1K. The closest competitors by value are STALLION LABORATORIES PRIVATE LIMITED and MACLEODS PHARMACEUTICALS LTD.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 597 | 17.0% |
| DELHI AIR CARGO ACC (INDEL4) | 514 | 14.6% |
| SAHAR AIR | 509 | 14.5% |
| DELHI AIR | 282 | 8.0% |
| NHAVA SHEVA SEA (INNSA1) | 238 | 6.8% |
| Bombay Air | 172 | 4.9% |
| HYDERABAD ICD (INSNF6) | 112 | 3.2% |
| Delhi Air | 110 | 3.1% |
Latest developments and market context
Detailed market intelligence for Lisinopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Richterthemis Medicare India Private Limited's Lisinopril exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| MALTA |
| $532.8K |
| 67 |
| LUPIN PHARMACEUTICALS INC | UNITED STATES | $200.0K | 4 |
| MYLAN B,V, | NETHERLANDS | $150.0K | 3 |
| GEDEON RICHTER PLC | HUNGARY | $150.0K | 3 |
| MYLAN IRELAND C/O ALLOGA RDC, | NETHERLANDS | $100.0K | 2 |
| XXALLXXT PXXRMAXXUTIXXLS XXALTXXLLCX | UNITED STATES | $100.0K | 2 |
India's Lisinopril is purchased by 450 buyers worldwide. The top buyer is LUPIN PHARMACEUTICAL INC (UNITED STATES), followed by BROWN AND BURK UK LIMITED and XXPINXXHARXXCEUXXCALXXINC.
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 450+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Richterthemis Medicare India Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lisinopril. For current shipment-level data, contact TransData Nexus.